Sanofi (LON:0A2V)

Market Cap	95.24B
Revenue (ttm)	36.62B
Net Income (ttm)	4.60B
Shares Out	n/a
EPS (ttm)	3.67
PE Ratio	20.71
Forward PE	n/a
Dividend	1.18 (2.38%)
Ex-Dividend Date	May 9, 2025

Volume	537
Average Volume	11,370
Open	50.20
Previous Close	50.99
Day's Range	48.93 - 50.21
52-Week Range	35.79 - 46.86
Beta	n/a
RSI	37.50
Earnings Date	Apr 24, 2025

About Sanofi

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. The company provides immunology and inflammation, rare diseases, neurology, oncology, and other medicines and vaccines. It also offers poliomyelitis, pertussis, and haemophilus influenzae type b (Hib) pediatric vaccines; respiratory syncytial virus protection and hexavalent combination vaccines protecting against diphtheria, tetanus, pertussis, polio, Hib, and hepatitis B; inf...

• Industry: Pharmaceutical Preparations
• Founded: 1994
• Employees: 82,878
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0A2V

Financial Performance

In 2024, Sanofi's revenue was 44.29 billion, an increase of 7.73% compared to the previous year's 41.11 billion. Earnings were 5.56 billion, an increase of 2.96%.

Financial numbers in EUR